BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30201762)

  • 1. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
    Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
    Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of targeted near-infrared imaging agents for prostate cancer.
    Wang X; Huang SS; Heston WD; Guo H; Wang BC; Basilion JP
    Mol Cancer Ther; 2014 Nov; 13(11):2595-606. PubMed ID: 25239933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.
    Wang X; Ramamurthy G; Shirke AA; Walker E; Mangadlao J; Wang Z; Wang Y; Shan L; Schluchter MD; Dong Z; Brady-Kalnay SM; Walker NK; Gargesha M; MacLennan G; Luo D; Sun R; Scott B; Roy D; Li J; Basilion JP
    Cancer Res; 2020 Jan; 80(2):156-162. PubMed ID: 31719100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer.
    Neuman BP; Eifler JB; Castanares M; Chowdhury WH; Chen Y; Mease RC; Ma R; Mukherjee A; Lupold SE; Pomper MG; Rodriguez R
    Clin Cancer Res; 2015 Feb; 21(4):771-80. PubMed ID: 25501577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial.
    Stibbe JA; de Barros HA; Linders DGJ; Bhairosingh SS; Bekers EM; van Leeuwen PJ; Low PS; Kularatne SA; Vahrmeijer AL; Burggraaf J; van der Poel HG
    Lancet Oncol; 2023 May; 24(5):457-467. PubMed ID: 37062295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection.
    Jiao J; Zhang J; Wen W; Qin W; Chen X
    Theranostics; 2024; 14(7):2736-2756. PubMed ID: 38773975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
    Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
    Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
    [No Abstract]   [Full Text] [Related]  

  • 10. Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.
    Laydner H; Huang SS; Heston WD; Autorino R; Wang X; Harsch KM; Magi-Galluzzi C; Isac W; Khanna R; Hu B; Escobar P; Chalikonda S; Rao PK; Haber GP; Kaouk JH; Stein RJ
    Urology; 2013 Feb; 81(2):451-6. PubMed ID: 23374828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.
    Pagoto A; Garello F; Marini GM; Tripepi M; Arena F; Bardini P; Stefania R; Lanzardo S; Valbusa G; Porpiglia F; Manfredi M; Aime S; Terreno E
    Mol Imaging Biol; 2020 Feb; 22(1):85-93. PubMed ID: 31025163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a novel BODIPY-labeled PSMA inhibitor.
    Son SH; Kwon H; Ahn HH; Nam H; Kim K; Nam S; Choi D; Ha H; Minn I; Byun Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126894. PubMed ID: 31874825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA-targeted NIR probes for image-guided detection of prostate cancer.
    Cilibrizzi A; Wang JT; Memdouh S; Iacovone A; McElroy K; Jaffar N; Young JD; Hider RC; Blower P; Al-Jamal K; Abbate V
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112734. PubMed ID: 35952398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.
    Mazzocco C; Fracasso G; Germain-Genevois C; Dugot-Senant N; Figini M; Colombatti M; Grenier N; Couillaud F
    Sci Rep; 2016 Mar; 6():23314. PubMed ID: 26996325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
    Chen Y; Minn I; Rowe SP; Lisok A; Chatterjee S; Brummet M; Banerjee SR; Mease RC; Pomper MG
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fluorescent, [
    Guo H; Kommidi H; Vedvyas Y; McCloskey JE; Zhang W; Chen N; Nurili F; Wu AP; Sayman HB; Akin O; Rodriguez EA; Aras O; Jin MM; Ting R
    ACS Chem Biol; 2019 Jul; 14(7):1449-1459. PubMed ID: 31120734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of optimal target genes for detecting micrometastases in pelvic lymph nodes in patients with prostate cancer undergoing radical prostatectomy by real-time reverse transcriptase-polymerase chain reaction.
    Kusuda Y; Miyake H; Kurahashi T; Fujisawa M
    Urol Oncol; 2013 Jul; 31(5):615-21. PubMed ID: 21600799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
    Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
    Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation.
    Capozza M; Stefania R; Dinatale V; Bitonto V; Conti L; Grange C; Skovronova R; Terreno E
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.